Recent news and posts
A new coverage with evidence development scheme was announced in the Netherlands
In July 2025, the Dutch Healthcare Institute (ZIN) announced the establishment of a new policy framework named “Reimbursement within Research” (Vergoeding in Onderzoek). This framework allows temporary reimbursement from basic health insurance for existing care with insufficient evidence of effectiveness, conditional on further collection of evidence for evaluation. The policy will apply to specialist medical care, paramedical care, and medical devices.
Before applying the policy framework, ZIN will conduct an implementation review to define the processes, assess feasibility, and estimate potential risks. The draft implementation assessment is planned to be published by August 31, 2025. Stakeholders will be invited to provide feedback in September 2025.
The launch of the new framework is scheduled for November 1, 2025.
The full details in Dutch can be found here.
This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Contact us to get a free, three-month, no-obligation trial.